AT&T (T) earnings bounce: key levels as AI stocks rip

Last updated July 22, 2026
Table of Contents

Markets sift catalysts from noise

Risk appetite is still alive, but it has grown fussier.

AT&T’s post-earnings bounce, Repligen’s $1.5 billion life-sciences deal, and another burst of AI-infrastructure headlines frame today’s tape. Meanwhile, U.S. equity benchmarks remain close to record territory, while gold has firmed again. That pairing says plenty. Investors will take risk, however they want catalysts, cash flow, and cleaner setups.

Telecom: AT&T tests a sturdier uptrend

AT&T, ticker T, delivered second-quarter results that beat expectations and showed better subscriber additions than analysts had pencilled in. The stock rose modestly after the report, extending a recovery that has turned a sleepy dividend name into a credible momentum candidate.

Options activity has also leaned bullish, with call buyers positioning for more upside over the next month. Therefore, the post-earnings low now matters. If T holds above that level, traders can treat the move as consolidation inside a new uptrend.

However, a break below that low on heavy volume would change the message quickly. It would suggest the earnings bounce failed, inviting mean-reversion selling.

For income investors, the story is less dramatic. AT&T is rebuilding trust through subscribers, cash generation, and a dividend that still matters. It is not a revolution. Still, boring can work when the chart stops leaking.

Life sciences: Repligen buys scale

Repligen, ticker RGEN, has moved from speculation to action. The company agreed to buy BioLife Solutions, ticker BLFS, in a cash-and-stock transaction worth about $1.5 billion. BioLife holders are set to receive roughly $31 a share through the deal mix.

As a result, BLFS now behaves less like a growth stock and more like a merger-arbitrage trade. Upside depends on the spread to the deal price, closing risk, and timing. Fundamental surprises matter less from here.

The more interesting chart belongs to RGEN. Management is pitching the acquisition as strategically important for cell and gene therapy tools. Investors will now judge whether the premium buys revenue, margin expansion, and a wider moat.

For day traders, VWAP will matter early. A firm hold above the post-announcement support zone would favour continuation. However, a weak close would suggest investors are questioning the price and integration risk.

Energy: EQT gets a good bad reaction

EQT produced the sort of reaction traders notice. Earnings and sales missed expectations, yet the stock rose as analysts lifted forecasts and targets.

That is often useful information. When a stock climbs on weak headline numbers, expectations were probably lower than published estimates suggested. Alternatively, investors may care more about the next gas cycle than the last quarter.

Technically, the earnings-day low becomes the pivot. Above it, EQT can attract short-covering and trend followers. Below it, the setup flips into a failed breakout.

Meanwhile, the sector backdrop matters. If natural-gas peers strengthen, EQT’s move gains credibility. If peers lag, this may prove a single-name rerating rather than a durable shift.

AI infrastructure: Story stocks still have oxygen

The liveliest speculation remains near AI infrastructure. That means cloud platforms, data centres, power supply, and anything tied to compute demand.

CoreWeave, ticker CRWV, has benefited from a bullish analyst upgrade and higher price targets. In hot themes, such notes can drive one to three days of momentum. However, that momentum needs volume, not just pre-market excitement.

Traders will watch whether CRWV opens firm and defends intraday support. If it loses the upgrade-day low, the move starts looking note-driven rather than conviction-backed.

DigitalOcean, ticker DOCN, sits in a similar lane. The smaller cloud platform often trades on sentiment because it offers a cleaner mid-cap cloud expression. Therefore, relative strength against QQQ and other cloud names is the filter.

Oklo, ticker OKLO, is the wilder card. The nuclear start-up has caught attention through reports linking advanced nuclear power with AI data-centre demand. Mentions alongside Microsoft and Nvidia do little for those giants’ earnings. For Oklo, however, the association is powerful.

That makes OKLO a high-volatility story stock. It suits traders with tight stops, not casual dip-buyers. A hold above the news-day low favours continuation. A break below it could bring a sharp unwind.

Mega-caps: Earnings become macro events

Alphabet, Microsoft, and Meta enter earnings season with investors focused on AI capex, cloud growth, and margins. These reports are no longer just company events. They can move indexes, rates sentiment, and the broader AI trade.

For GOOGL, MSFT, and META, pre-earnings stock direction may prove less useful than options pricing. Implied volatility, skew, and expected moves define the battlefield. Consequently, many sophisticated traders prefer defined-risk option structures over binary stock bets.

After the numbers land, the first 30 to 60 minutes usually matter most. If institutions buy the initial dip, traders notice. If rallies fade on heavy volume, the market has probably rejected the print.

IBM, ticker IBM, offers the steadier version of the same theme. Investors will parse software, consulting, hybrid cloud, and AI services. Yet IBM normally trades more like a classic earnings gap setup than a speculative AI rocket.

Semiconductors: ARM remains a sentiment gauge

ARM remains a favoured way to play AI architecture without owning another pure GPU name. Its designs dominate mobile devices and increasingly touch data-centre and AI workloads.

However, valuation remains demanding. That leaves ARM highly sensitive to semiconductor sentiment and risk appetite.

For active traders, ARM is best treated as a relative-strength vehicle. Long setups improve when it breaks consolidation and beats the SOX index. Shorts require failed resistance and real selling volume, not merely a rich multiple.

Losers: Gaps need reasons

Pegasystems, ticker PEGA, is dealing with a post-earnings gap down after missing on revenue and profit. That puts the name firmly in the bearish short-term camp.

Rallies into resistance may attract sellers. Meanwhile, breaks below pre-market lows can offer momentum entries. A durable long would require PEGA to reclaim much of the gap quickly, which is a lower-probability first-day outcome.

Adtran, ticker ADTN, and Dyne Therapeutics, ticker DYN, also appear among pre-market losers. However, traders need the driver before risking capital. Earnings, guidance, regulatory updates, and sector moves create very different odds.

Without a clear negative catalyst, these names are volatility flags rather than clean trades. If bad news meets heavy volume, continuation can work. If the news is mild and buyers defend the lows, fade setups become possible.

By the numbers

  • $1.5 billion: Repligen’s agreed value for BioLife Solutions.
  • About $31: Implied BioLife per-share consideration in cash and stock.
  • 30 to 60 minutes: Key post-earnings window for reading institutional reaction.
  • One to three days: Typical momentum window for strong upgrades in hot themes.
  • Second quarter: AT&T’s earnings period that reset the stock’s trading level.

Key takeaways

  • T: Bullish while it holds above the post-earnings low.
  • RGEN: Watch support and VWAP as investors judge the BioLife deal.
  • EQT: Strength after a miss is constructive, unless the earnings-day low breaks.
  • CRWV, DOCN, OKLO: AI-infrastructure trades need tight levels and volume confirmation.
  • GOOGL, MSFT, META: Options may offer cleaner risk than outright pre-earnings stock bets.

The market’s message is selective rather than euphoric. Catalysts matter. So do levels. In this tape, the best trades have a reason, a time frame, and a clean exit before the story turns stale.

Start Your Days Smarter!

One Wallet. Then Invest. Then Trade.

Volity is your all-in-one hub for money movement, market access, and financial clarity.

High-Risk Investment Notice:  Website information does not contain and should not be construed as containing investment advice, investment recommendations, or an offer or solicitation of any transaction in financial instruments. It has not been prepared in accordance with legal requirements designed to promote the independence of investment research, and it is not subject to any prohibition on dealing ahead of the dissemination of investment research. Nothing on this site should be read or construed as constituting advice on the part of Volity Trade or any of its affiliates, directors, officers, or employees.

Please note that content is a marketing communication. Before making investment decisions, you should seek out independent financial advisors to help you understand the risks.

Services are provided by Volity Trade Ltd, registered in Saint Lucia, with the number 2024-00059. You must be at least 18 years old to use the services.

Trading forex (foreign exchange) or CFDs (contracts for difference) on margin carries a high level of risk and may not be suitable for all investors. There is a possibility that you may sustain a loss equal to or greater than your entire investment. Therefore, you should not invest or risk money that you cannot afford to lose. The products are intended for retail, professional, and eligible counterparty clients. For clients who maintain account(s) with Volity Trade Ltd., retail clients could sustain a total loss of deposited funds but are not subject to subsequent payment obligations beyond the deposited funds. Professional and eligible counterparty clients could sustain losses in excess of deposits.

Volity is a trademark of Volity Capital L.L.C-FZ, registered in Dubai, U.A.E., with the number 2423068.
Volity Invest Ltd, number HE 452984, registered at Archiepiskopou Makariou III, 41, Floor 1, 1065, Lefkosia, Cyprus is acting as a payment agent of Volity Trade Ltd.

Volity Trade Ltd. is an introductory broker for UBK Markets Ltd. It offers execution and custody services for clients introduced by Volity. UBK Markets Ltd is authorised and regulated by the Cyprus Securities and Exchange Commission (CySEC), license number 186/12 and registered at 67, Spyrou Kyprianou Avenue, Kyriakides Business Center, 2nd Floor, CY-4003 Limassol, Cyprus.

Volity Trade Ltd. does not offer services to citizens/residents of certain jurisdictions, such as the United States, and is not intended for distribution to or use by any person in any country or jurisdiction where such distribution or use would be contrary to local law or regulation.

Copyright: © 2026 Volity Trade Ltd. All Rights reserved.